SCHEMBL6629142

SCHEMBL6629142

CC(C)C1C(c2ccccc2)=C(c2ccccc2)c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 1/20 0.39
CDC25B P30305 1/20 0.39
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MITF O75030 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.35
HSP90AA1 P07900 2/20 0.34
HSP90AB1 P08238 2/20 0.34
CYP1A2 P05177 1/20 0.33
TSHR P16473 1/20 0.33
P2RX7 Q99572 1/20 0.33
FGFR1 P11362 4/20 0.33
FGFR2 P21802 4/20 0.33
FGFR4 P22455 4/20 0.33
FGFR3 P22607 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL132885 0.78 CYP1A2 (0.31) MAPTALDH1A1NPSR1MITFHTT
SCHEMBL27916062 0.76 ALDH1A1 (0.35) CDC25ACDC25BMAPTALDH1A1NPSR1
SCHEMBL3919889 0.74 GPR3 (0.46) MEN1KMT2APOLBATMCYP1A2
SCHEMBL27363609 0.72 ALDH1A1 (0.39) MAPTALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL6626602 0.71 HSP90AA1 (0.35) CDC25ACDC25BMAPTALDH1A1NPSR1
SCHEMBL232990 0.70 LMNA (0.41) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL6633153 0.69 MEN1 (0.38) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL4403411 0.67 CDC25B (0.52) CDC25ACDC25BMAPTALDH1A1NPSR1
Ammonia Solution, Strong SCHEMBL27746239 0.67 MEN1 (0.35) MEN1KMT2APOLBATMCYP1A2
SCHEMBL6632251 0.66 MAPT (0.43) MAPTALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1033130-B1 INHIBITOR OF UROKINASE PRODUCTION AND OF ANGIOGENESIS AND ITS THERAPEUTIC USE TAIHO PHARMACEUTICAL CO LTD (JP) 2004-04-21 EP disclosed
US-6365610-B1 1,4-EPOXY-2,3-BENZODIOXEPINS OR 1,4-EPOXY-3,2-BENZOXAZEPINES TAIHO PHARMACEUTICAL COMPANY LTD. (JP) 2002-04-02 US disclosed
EP-1033130-A1 UROKINASE PRODUCTION INHIBITORS, ANGIOGENESIS INHIBITORS AND METHODS OF PREVENTION OR TREATMENT WITH BOTH TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 2000-09-06 EP disclosed